How the eye's light-sensing pigments work and how drugs might help
Chemical Biology of the Visual Pigments
This project looks at how the eye's light-detecting pigments change after light and how small drug-like molecules could help people with retinal diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11303284 on NIH RePORTER |
What this research studies
This research uses lab-grown versions of the eye's light-sensing proteins and advanced chemical tools to watch how they change shape after light exposure. Scientists will map short-lived intermediate forms, follow how the retinal molecule is released, and test how small drug-like compounds interact with the pigments. The team will apply new chemical probes, spectroscopy, and structural imaging to reveal steps that were previously too fast or too small to observe. Learning these details could point to ways to protect or restore light detection in retinal diseases.
Who could benefit from this research
Good fit: People with inherited or degenerative retinal conditions that affect photoreceptor function, or those willing to donate eye tissue or participate in future related trials, would be most relevant.
Not a fit: Patients whose vision problems are due to non-photoreceptor causes (for example optic nerve damage or uncorrected refractive error) are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, the work could identify new targets or strategies for medicines that slow or repair vision loss from retinal pigment problems.
How similar studies have performed: Previous laboratory studies have revealed parts of rhodopsin activity and some small molecules showed promise in models, but detailed photointermediate structures and the exact mechanism of retinal release remain incompletely mapped.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Kiser, Philip David — University of California-Irvine
- Study coordinator: Kiser, Philip David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.